A slower rate of infusion for the first DARZALEX® dose is usually recommended, as infusion reactions are more likely to take place through the first infusion2 You may need Recurrent liver functionality assessments though using this medicine and for several months after you stop. Darzalex has the Lively ingredient daratumumab. https://adhdozempic.com/